1. Home
  2. Companies
  3. 4DX
  4. Material Events

4Dmedical (ASX:4DX) — Material Events

ASX:4DX · 36 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major 15 articles Significant 18 articles Notable 3 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Major Score 90+
15
4DMedical Secures European Foothold with contextflow AcquisitionHigh
4DMedical acquires contextflow to establish European platform and expand lung health market presence
1 June 2026 ·Acquisition Announcement ·90
4DMedical’s CT:VQ™ Breakthrough Fuels 43% SaaS Growth and $150M Capital RaiseHigh
4DMedical reports strong H1 FY26 growth, FDA clearance for CT:VQ™, $150M placement boosts cash position
27 Feb 2026 ·Half-year Financial Report ·90
4DMedical Accelerates CT:VQ Adoption with $233m Raise and EU, UK ClearancesHigh
4DMedical accelerates CT:VQ adoption, secures GSK contract, achieves EU and UK regulatory clearances, raises $233m, and joins ASX 200
30 Apr 2026 ·Quarterly Activity Report and Appendix 4C ·90
4DMedical Secures CE Mark and $83M to Accelerate European Lung Imaging RolloutHigh
4DMedical secures CE Mark for CT:VQ™ and raises $83M to expand in Europe
27 Mar 2026 ·Capital Raising ·90
4DMedical Accelerates Growth with $10M Pro Medicus Investment and FDA MilestoneHigh
4DMedical posts 56% revenue growth, secures $10m investment, advances FDA clearance for CT:VQ™
31 July 2025 ·Quarterly Activity Report and Appendix 4C ·90
4DMedical Accelerates CT – VQ™ Rollout with $150M Raise and Philips DealHigh
4DMedical accelerates CT:VQ™ commercialisation with FDA clearance, Philips deal, $150M placement, and Canadian approval
30 Jan 2026 ·Quarterly Activity Report and Appendix 4C ·90
Mayo Clinic Adopts 4DMedical’s CT:VQ™, Boosting US Market MomentumMedium
Mayo Clinic Deploys 4DMedical's CT:VQ™, Sixth Top US Academic Medical Center Adoption
25 Mar 2026 ·Commercial Deployment Announcement ·90
4DMedical Accelerates Growth with FDA Bid and $10m Pro Medicus BoostHigh
4DMedical posts 56% revenue growth, advances FDA clearance for CT:VQ™, secures $10m Pro Medicus investment and Philips reseller deal
29 Aug 2025 ·Full Year Results ·90
4DMedical’s CT, VQ™ Wins FDA Nod, Poised to Disrupt Lung Imaging MarketHigh
4DMedical Secures FDA Clearance for Groundbreaking CT:VQ™ Lung Imaging Technology
1 Sept 2025 ·Regulatory Approval ·90
4DMedical Secures $150M to Boost US Launch of FDA-Cleared CT – VQ ImagingHigh
4DMedical raises AU$150M to accelerate US rollout of FDA-cleared CT:VQ lung imaging with Philips partnership
19 Jan 2026 ·Investor Presentation ·90
4DMedical’s CT, VQ™ Wins FDA Nod and CMS Reimbursement, Igniting Global Lung Imaging ExpansionHigh
4DMedical achieves FDA clearance and CMS reimbursement for CT:VQ™, expands global commercial footprint, and reports strong Q1 FY26 financials
30 Oct 2025 ·Quarterly Activity Report and Appendix 4C ·Unexpected ·90
4DMedical Secures GSK Contract and UK Clearance as CT:VQ™ Expands Global ReachMedium
4DMedical secures GSK contract, UK clearance for CT:VQ™, US CAC reimbursement, and ASX 200 inclusion
20 Apr 2026 ·Corporate Announcement ·90
4DMedical Secures Canadian Approval, Poised to Transform North American Lung ImagingHigh
4DMedical gains Canadian regulatory approval for CT:VQ™, expands North American market access via Philips partnership
15 Dec 2025 ·Regulatory Approval Announcement ·90
4DMedical Secures US$10m Philips Deal to Revolutionize Lung Imaging in North AmericaHigh
4DMedical secures US$10m Philips deal to distribute CT:VQ™ lung imaging in North America
3 Dec 2025 ·ASX announcement ·90
4DMedical Secures $650 Medicare Reimbursement, Poised for US Lung Imaging BreakthroughHigh
4DMedical secures US$650.50 CMS reimbursement for CT:VQ™, enabling U.S. commercial launch
3 Sept 2025 ·Regulatory/Reimbursement Announcement ·90
Significant Score 75–89
18
4DMedical Secures $10m Boost from Pro Medicus to Fast-Track Lung Imaging InnovationMedium
4DMedical secures $10m strategic investment from Pro Medicus to accelerate growth and FDA clearance
31 July 2025 ·Capital Raising ·85
4DMedical Secures $30.2M Underwriting Boost Ahead of Transformational 2026Medium
4DMedical secures $30.2M via option underwriting, boosting cash to $63.7M, eyes transformational 2026
12 Dec 2025 ·Capital Raising ·85
Stanford Leads US Rollout of 4DMedical’s CT – VQ™ as Brazil Program ExpandsMedium
4DMedical launches CT:VQ™ at Stanford and expands AstraZeneca lung screening in Brazil
22 Oct 2025 ·Commercial Partnership Announcement ·85
University of Miami Advances Clinical Use of 4DMedical’s CT – VQ™ TechnologyMedium
University of Miami adopts 4DMedical's CT:VQ™; Lahey Hospital signs two-year IQ-UIP™ deal
10 Dec 2025 ·Commercial Agreement Announcement ·85
University of Chicago Medicine Expands Use of 4DMedical’s CT – VQ™ TechnologyMedium
University of Chicago Medicine expands commercial use of 4DMedical's CT:VQ™ lung imaging technology
30 Jan 2026 ·Commercial Partnership Announcement ·85
4DMedical Secures $150M to Fast-Track US Rollout of CT – VQ™ TechnologyHigh
4DMedical raises $150M to accelerate U.S. commercialization of CT:VQ™ with strong institutional support
15 Jan 2026 ·Capital Raising ·85
4DMedical Study Boosts Lung Surgery Success with CT:VQ™ ValidationMedium
4DMedical's CT:VQ™ validated in leading respiratory journal, boosts lung surgery outcomes and economics
19 May 2026 ·Clinical Study Publication Announcement ·85
UC San Diego Health Boosts Lung Imaging with 4DMedical’s CT – VQ™Medium
UC San Diego Health adopts 4DMedical's CT:VQ™, fourth major U.S. academic center to deploy technology
7 Jan 2026 ·Commercial Adoption Announcement ·85
4DMedical Targets $3B US Pulmonary Embolism Market with New CLEAR ProgramMedium
4DMedical launches CLEAR program targeting US$3B acute pulmonary embolism market with CT:VQ™
2 June 2026 ·Clinical Program Launch ·85
Cleveland Clinic Joins Elite US Centres Adopting 4DMedical’s CT – VQ™Medium
Cleveland Clinic adopts 4DMedical's CT:VQ™ technology, third major US academic medical centre to do so post-FDA clearance
19 Dec 2025 ·Commercial Adoption Announcement ·85
4DMedical Secures Major US Outpatient Deal with SimonMed for CT:VQ™Medium
4DMedical inks 3-year commercial deal with SimonMed Imaging for US outpatient CT:VQ™ deployment
29 May 2026 ·Commercial Contract Announcement ·85
4DMedical Expands Lung Screening Reach with Major Deals in Brazil and AustraliaMedium
4DMedical inks multi-year deals to expand lung health screening in Brazil and Australia
8 Sept 2025 ·Partnership Announcement ·85
4DMedical Secures TGA Nod for CT:VQ™ Unlocking Australia RolloutMedium
4DMedical secures TGA approval for CT:VQ™ in Australia enabling commercial rollout
26 June 2026 ·Regulatory Approval ·85
4DMedical Strengthens Cash Position with $6M R&D Credit and Validates COPD Imaging TechMedium
4DMedical boosts cash with $6M R&D credit and publishes breakthrough COPD imaging study
2 Sept 2025 ·Corporate Update ·85
4DMedical Secures Key US Contract Renewal and Advances AI Lung DiagnosticsMedium
4DMedical renews University of Michigan contract, publishes key clinical study, and secures AUD$1.1m AEA grant
18 July 2025 ·Contract Renewal and Grant Announcement ·80
4DMedical Defends Disclosure on US Hospital Deals Ahead of $150M RaiseMedium
4DMedical clarifies ASX queries on commercial agreements and denies ramping ahead of $150M capital raise
30 Jan 2026 ·ASX Query Response ·80
4DMedical Raises $22.6M, Boosting Cash to $45.5M Ahead of Key US ExpansionMedium
4DMedical raises $22.6M via option exercises, cash balance now $45.5M
3 Oct 2025 ·Capital Raising ·80
4DMedical Boosts Revenue 56% but Posts $30M Loss Amid Strategic Funding PushMedium
4DMedical FY2025 revenue rises 56%, net loss narrows to $30.1M; raises $13.9M capital and secures $10M funding facility
29 Aug 2025 ·Appendix 4E - Preliminary Final Report ·75
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.

Market Mentions 21 - appeared in market wrap coverage

These are market wrap articles where 4Dmedical (ASX:4DX) was mentioned. They reflect broader market coverage, not company-specific announcements.

Market Wrap - Week 26 (22 June -> 26 June) 2026
27 June 2026
Wrap
Healthcare Wrap - Week 26 (22 June -> 26 June) 2026
27 June 2026
Wrap
Market Wrap - Week 23 (1 June -> 5 June) 2026
6 June 2026
Wrap
Healthcare Wrap - Week 23 (1 June -> 5 June) 2026
6 June 2026
Wrap
Healthcare Wrap - Week 22 (25 May -> 29 May) 2026
30 May 2026
Wrap